But it also raises IGF-1, disrupts glucose metabolism, and can accelerate unwanted tissue growth
BPC-157 Route Selection Oral BPC-157 (250 to 500 mcg, 1 to 2 times daily on an empty stomach): Best for patients whose primary goal is GI support during GLP-1 therapy
Side Effect Profiles Whether semaglutide comes in a pill or injection, the most common side effects are the same: Stomach pain Yellow skin or eyes Fever Sweating Dizziness Anxiety Nausea Bloating Vomiting Constipation Diarrhea Faster heartbeat Shakiness or weakness Headaches Blurred vision Fatigue Interestingly, oral and injectable options have about the same risk of adverse side effects
An injection addresses that deficit everywhere at once, not just in one tissue or organ
Administered in research settings, BPC-157 demonstrated systemic healing properties
Research Background Preclinical research on Epitalon has focused on its ability to activate telomerase, the enzyme responsible for maintaining telomere length